Changes in histaminergic system in neuropsychiatric disorders and the potential treatment consequences

Curr Neuropharmacol. 2021 Sep 9. doi: 10.2174/1570159X19666210909144930. Online ahead of print.ABSTRACTIn contrast to that of other monoamine neurotransmitters, the association of the histaminergic system with neuropsychiatric disorders is not well documented. In the last two decades, several clinical studies involved in the development of drugs targeting the histaminergic system have been reported. These include the H3R-antagonist/inverse agonist, pitolisant, used for the treatment of excessive sleepiness in narcolepsy, and the H1R antagonist, doxepin, used to alleviate symptoms of insomnia. The current review summarizes reports from animal models, including genetic and neuroimaging studies, as well as human brain samples and cerebrospinal fluid measurements from clinical trials, on the possible role of the histaminergic system in neuropsychiatric disorders. These studies will potentially pave the way for novel histamine-related therapeutic strategies.PMID:34521328 | DOI:10.2174/1570159X19666210909144930
Source: Current Neuropharmacology - Category: Drugs & Pharmacology Authors: Source Type: research

Related Links:

CONCLUSION: The target engagement of enerisant was demonstrated in the brains of living human subjects. The occupancy of histamine H3 receptors by enerisant at 2 h can be predicted by applying the plasma concentration of enerisant to Hill's plot. The preliminary time-course investigation showed persistently high brain occupancy with high doses of enerisant despite the decreasing plasma concentration of the drug. Five milligrams or less dose would be appropriate for the treatment for narcolepsy with initially high occupancy allowing for effective treatment of narcolepsy, and then the occupancy level would be expected to dec...
Source: Molecular Medicine - Category: Molecular Biology Authors: Source Type: research
J Sleep Res. 2021 Jun 24:e13426. doi: 10.1111/jsr.13426. Online ahead of print.ABSTRACTThe analysis of sleep microstructure in attention deficit hyperactivity disorder (ADHD) revealed an under-representation of the EEG slow component during NREM sleep. Previous studies either excluded or did not characterize objectively sleep disorders, which notoriously affect sleep architecture. The present study aimed to investigate the cyclic alternating pattern in a real clinical sample of children with ADHD, in whom sleep disorders could be considered. Twenty-seven consecutively enrolled drug-naïve children (mean age, 10.53 year...
Source: Journal of Sleep Research - Category: Sleep Medicine Authors: Source Type: research
Rev Neurol. 2021 Jun 16;72(12):411-418. doi: 10.33588/rn.7212.2020595.ABSTRACTAIM: The aim of this study is to determine whether there are any differences in the dream content in different sleep disorders and to describe their characteristics.PATIENTS AND METHODS: We studied four sleep disorders: sleep apnoea and hypopnoea syndrome (SAHS), primary insomnia (PI), idiopathic REM sleep behaviour disorder (IRBD) and narcolepsy type I. Each patient was asked to keep a dream diary for two weeks. The content of the diaries was transcribed and analysed for length, mental content, complexity and threat. The results were compared to...
Source: Revista de Neurologia - Category: Neurology Authors: Source Type: research
Front Neurol Neurosci. 2021;45:22-37. doi: 10.1159/000514963. Epub 2021 May 28.ABSTRACTThe hypocretins/orexins are two excitatory neuropeptides, alternately called HCRT1 or orexin-A and HCRT2 or orexin-B, that are the endogenous ligands for two G-protein-coupled receptors, HCRTR1/OX1R and HCRTR2/OX2R. Shortly after the discovery of this system, degeneration of hypocretin/orexin-producing neurons was implicated in the etiology of the sleep disorder narcolepsy. The involvement of this system in a disorder characterized by the loss of control over arousal state boundaries also suggested its role as a critical component of end...
Source: Frontiers of Neurology and Neuroscience - Category: Neuroscience Authors: Source Type: research
More News: Brain | Clinical Trials | Doxepin | Drugs & Pharmacology | Genetics | Insomnia | Narcolepsy | Neurology | Sleep Medicine | Study